High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion

Atherosclerosis

Volumn 210, Issue 1, 2010, Pages 278-281

  Sofi, Francesco ^a,b,c   Marcucci, Rossella ^a,b   Fedi, Sandra ^a,b   Giambene, Barbara ^a   Sodi, Andrea ^a   Menchini, Ugo ^a   Gensini, Gian Franco ^a,b,c   Abbate, Rosanna ^a,b   Prisco, Domenico ^a,b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Lipoprotein (a); Retinal vein occlusion; Risk factor; Thrombosis

Indexed keywords

HOMOCYSTEINE; LIPOPROTEIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA VEIN OCCLUSION; RISK ASSESSMENT; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; LIPOPROTEIN(A); LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETINAL VEIN OCCLUSION; RISK FACTORS;

EID: 77952427933     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.11.006     Document Type: Article

References (34)

1. Klein R., Klein B.E., Moss S.E., Meuer S.M. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000, 98:133-141.
2. Cugati S., Wang J.J., Rochtchina E., Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol 2006, 124:726-732.
3. Cugati S., Wang J.J., Knudtson M.D., et al. Retinal vein occlusion and vascular mortality. Pooled data analysis of 2 population-based cohorts. Ophthalmology 2007, 114:520-524.
4. Prisco D., Marcucci R., Bertini L., Gori A.M. Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Intern Med 2002, 13:163-169.
5. Marcucci R., Bertini L., Giusti B., et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 2001, 86:772-776.
6. Gori A.M., Marcucci R., Fatini C., et al. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels. Thromb Haemost 2004, 92:54-60.
7. Sofi F., Marcucci R., Bolli P., et al. Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis 2008, 198:223-227.
8. Sofi F., Mannini L., Marcucci R., et al. Role of haemorheological factors in patients with retinal vein occlusion. Thromb Haemost 2007, 98:1215-1219.
9. Berglund L., Ramakrishan R. Lipoprotein (a). An elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 2004, 24:2219-2226.
10. Muller H.M., Diekstall F.F., Schmidt E., et al. Lipoprotein (a): a risk factor for retinal vascular occlusion. Ger J Ophthalmol 1992, 1:338-341.
11. Bandello F., Viganò D'Angelo S., Parlavecchia M., et al. Hypercoagulability and high lipoprotein (a) levels in patients with central retinal vein occlusion. Thromb Haemost 1994, 72:39-43.
12. Tavola A., Viganò D'Angelo S., Bandello F., et al. Central retinal vein and branch artery occlusion associated with inherited plasminogen deficiency and high lipoprotein (a) levels: a case-report. Thromb Res 1995, 80:327-331.
13. Lip P.L., Blann A.D., Jones A.F., Lip G.Y. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. Eye 1998, 12:245-251.
14. Murata M., Saito T., Takahashi S., Ichinose A. Plasma lipoprotein (a) levels are high in patients with central retinal artery occlusion. Thromb Res 1998, 91:169-175.
15. Stojakovic T., Scharnagl H., Marz W., et al. Low density lipoprotein triglycerides and lipoprotein (a) are risk factors for retinal vascular occlusion. Clin Chim Acta 2007, 382:77-81.
16. Wong T.Y., Larsen E.K.M., Klein R., et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli. Ophthalmology 2005, 112:540-547.
17. Cifkova R., Erdine S., Fagard R., et al. ESH/ESC Hypertension Guidelines Committee. ESH/ESC hypertension guidelines committee. Practice guidelines for primary care physicians: 2003 ESH/ESC Hypertension guidelines. Hypertension 2003, 21:1779-1786.
18. Expert committee on the diagnosis, classification of diabetes mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26:5-20.
19. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (Adult Treatment in Panel III) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
20. Dembisnki T., Nixon P., Shen G., Mymin D., Choy P.C. Evaluation of a new apolipoprotein(a) isoform-independent assay for serum lipoprotein(a). Mol Cell Biochem 2000, 207:149-155.
21. Kwok S., Charlton-Menys V., Pemberton P., McElduff P., Durrington P.N. Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women. Maturitas 2006, 53:439-446.
22. Chan S.Y., Mancini G.B.J., Kuramoto L., et al. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003, 42:1037-1043.
23. Sofi F., Fatini C., Sticchi E., et al. Fish intake and LPA 93C>T polymorphism: gene-environment interaction in modulating lipoprotein (a) concentrations. Atherosclerosis 2007, 195:e147-e154.
24. Smolders B., Lemmens R., Thijs V. Lipoprotein (a) and stroke: a meta-analysis of observational studies. Stroke 2007, 38:1959-1966.
25. Sofi F., Marcucci R., Abbate R., Gensini G.F., Prisco D. Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis. Am J Med 2007, 120:728-733.
26. Sundvall J., Sulonen G.B., Hiltunen O., et al. Comparison of a new immunoturbidometric assay of human serum lipoprotein (a) to the ELISA and the IRMA methods. Scand J Clin Lab Invest 1995, 55:171-180.
27. Janssen M.C.H., Den Heijer M., Cruysberg J.R.M., Wollersheim H., Bredie S.J.H. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005, 93:1021-1026.
28. Liu A.C., Lawn R.M. Lipoprotein (a) and atherogenesis. Trends Cardiovasc Med 1994, 4:40-44.
29. Pursiainen M., Jauhiainen M., Ehnholm C. Low-density lipoprotein activates the protease region of recombinant apo(a). Biochim Biophys Acta 1994, 1215:170-175.
30. Grainger D.J., Kirschenlohr H.L., Metcalfe J.C., et al. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 1993, 260:1655-1658.
31. Boffa M.B., Marcovina S.M., Koschinsky M.L. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistics insights from animal models. Clin Biochem 2004, 37:333-343.
32. Riis Hansen P., Kharazmi A., Jauhiainen M., Ehnholm C. Induction of oxygen free radical generation in human monocytes by lipoprotein(a). Eur J Clin Invest 1994, 24:497-499.
33. Lippi G., Franchini M., Targher G. Platelets and lipoprotein (a) in retinal vein occlusion: mutual targets for aspirin therapy. Thromb Haemost 2007, 97:1059-1060.
34. Bambauer R., Schiel R., Latza R. Low-density lipoprotein apheresis: an overview. Ther Apher Dial 2003, 7:382-390.